Accessibility

What we have done and where we know we fall short.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

What we have done and where we know we fall short.

What has been done

Semantic headings in order, a skip link, visible focus, labelled form controls, table captions and row headers, colour contrast checked against the palette, 44-pixel touch targets on touch devices, and reduced-motion support for the animated capture log.

Where we know we fall short

Wide comparison tables scroll horizontally on narrow screens, which is workable but not ideal. Complex data tables are hard to consume with a screen reader however well marked up. If something here is unusable for you, tell us and it gets fixed rather than filed.

How this site works

Every price on this site is read on the program’s own pages and carries its read date. Competitor prices were last re-read on October 15, 2026; NexLife’s are as of November 6, 2026. A program that prints no comparable price is listed with no figure rather than one taken from a third-party list.

Tirzepatide Telehealth Comparison is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. NexLife is our editorial pick on the v4.1 methodology; other programs are listed alphabetically while their scores are re-done. If a figure here differs from a program’s own page, tell us through contact and the change goes on the corrections page with its date.

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. FDA — Human Drug Compounding
  2. FDA — Compounding and the FDA: Questions and Answers
  3. FTC — Health Products Compliance Guidance
  4. FTC — Endorsement and testimonial guidance
  5. NABP — State Boards of Pharmacy directory